We are Sorry, This Page doesn't Exist

Consolidating all Medicare drug payments under Part D sounds easy, but some cancer patients fear they'll take a hit......»»

Consolidating all Medicare drug payments under Part D sounds easy, but some cancer patients fear they'll take a hit......»»

In the debate over prescription drug prices, one group is being overlooked: people with rare diseases. The needs of these patients, who rely on specialty medications for their lives and livelihoods,... To view the full story, click the title link......»»

Agios Pharmaceuticals, Inc. (AGIO), initiates a phase III ACTIVATE study which will evaluateits lead rare genetic diseases candidate, AG-348 in patients with PK deficiency w.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Many patients continue to avoid health care settings for fear of exposing themselves to Covid-19......»»

The BridgeBio model is designed to move drugs tackling rare diseases with a well-defined genetic basis quickly and efficiently to approval......»»

Pandion’s lead drug candidate, PT101, last month met its main goals of safety and tolerability in an early-stage trial in patients with autoimmune diseases......»»

Horizon Therapeutics PLC (NASDAQ: HZNP), a rare and rheumatic diseases drug company, announced a multibillion-dollar deal Monday to snap up Viela Bio Inc (NASDAQ: VIE). read more.....»»

  Spain is one of the worst hit countries by the coronavirus pandemic. For healthcare workers on the front lines, treating dozens of patients a day comes with fear that they're putting themselves and their families at risk. Business Insider Today.....»»

The Mount Sinai Laboratory is one of only a handful of labs to receive emergency authorization from the Food and Drug Administration to test whether patients have the antibodies to fight off the... To view the full story, click the title link......»»

Alex Wong/Getty Images Emails obtained by Vanity Fair indicate the Trump administration cooked up a plan to distribute the unproven drug hydroxychloroquine to millions of COVID-19 sufferers. Brett Giroir, the Trump adviser overseeing the .....»»

PALO ALTO, Calif., March 13, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today reported financial resul.....»»

Fear that the plan crafted to house infected patients was flawed gave new energy to already circulating rumors and wild theories about the virus......»»

A shortage of the chemotherapy drug vincristine, which is essential to the treatment of most pediatric cancers, has caused tremendous worry for families who might rely on the drug for their child's treatment. With t.....»»

The National Institutes of Health has awarded Annovis Bio a $1.7 million grant to support the development of the Berwyn company's lead new drug candidate, which is being studied as a potential treatment for Alzheimer’s and Parkinson's diseases and .....»»

CAMBRIDGE, Mass., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (NASDAQ:FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that its f.....»»

Shares of Celgene Corp. [s:celg] rose 0.34% in afternoon trading after the U.S. Food and Drug Administration approved Reblozyl. The drug, which treats anemia in patients with beta thalassemia, a rare blood disorder, was developed jointl.....»»

Baltimore biopharmaceutical company AgeneBio Inc. has received more than $3 million in new funding to accelerate the development of a drug that could slow cognitive decline among Alzheimer's patients. AgeneBio is developing therapeutics, known as .....»»

While Georgia’s new medical marijuana law takes effect July 1, patients suffering from diseases qualifying them to obtain the drug legally likely will have to wait much longer for relief......»»